TickerFactsScreenerDevelopers

Royalty Pharma plc (RPRX) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2019: $246.20M2020: $1.01B2021: $1.54B2022: $1.71B2023: $477.01M2024: $929.03M2025: $618.70M$618.70M
2019Cash & Equivalents (USD)2025
Fiscal YearCash & EquivalentsChange YoY
2025$618.70M-33.4%
2024$929.03M+94.8%
2023$477.01M-72.1%
2022$1.71B+11.0%
2021$1.54B+52.8%
2020$1.01B+309.7%
2019$246.20M—